Stoke Therapeutics Inc (STOK) valuation · rev $184.4M
Stoke Therapeutics Inc (STOK) rev $184.4M.
| Metric | Value |
|---|---|
| Market cap | $1.88B |
| Revenue | $184.4M |
| P/S | 10.2 |
| P/B | 4.8 |
STOK valuation FAQ
What is STOK's market cap?
Stoke Therapeutics Inc (STOK) market cap is $1.88B on the latest cached fundamentals snapshot.
What is STOK's latest revenue?
Latest cached Stoke Therapeutics Inc (STOK) revenue was $184.4M. Statements: https://lician.com/financials/stok
What is STOK's price-to-sales ratio?
Stoke Therapeutics Inc (STOK) price-to-sales (P/S) is 10.2, cached market cap $1.88B divided by revenue $184.4M.
What is STOK's price-to-book ratio?
Stoke Therapeutics Inc (STOK) price-to-book (P/B) is 4.8 on the latest cached fundamentals snapshot.
How many STOK valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Stoke Therapeutics Inc (STOK): Market cap, Revenue, P/S, and P/B.
Where is STOK valuation listed?
Cached valuation multiples for Stoke Therapeutics Inc (STOK) are listed at https://lician.com/valuation/stok.
Not investment advice. Cached rows, not a live tape.